22 January, 2026

Singapore
First fibrotic disease drug of Singapore advances into Phase II clinical evaluation

Duke-NUS Medical School in Singapore has noted the announcement by Boehringer Ingelheim of a Phase IIa clinica...Read more

- 21 January 2026 News

North America
Australia's 4DMedical secures $100+ M funding to accelerate US expansion

Australia-based 4DMedical, the leader in software-based respiratory imaging technology, has announced $100+ million (AU$...Read more

- 21 January 2026 News


Japan
GSK and Shionogi agree to replace Pfizer's stake in ViiV Healthcare


GSK plc and Shionogi & Co. have reached an agreement together with Pfizer Inc. for the 11.7% economic interest in UK...Read more

- 21 January 2026 News


China
AstraZeneca buys remaining China rights to GPC3 armored CAR-T therapy from AbelZeta Pharma for $630 M


US-based AbelZeta Pharma, Inc., a global clinical-stage biopharmaceutical company focused on the discovery and developme...Read more

- 21 January 2026 News


Korea
Pacira partners with LG Chem to make EXPAREL® available in select APAC markets


US-based Pacira BioSciences, Inc. has entered into an agreement with South Korea's LG Chem designed to expand access to ...Read more

- 21 January 2026 News





All you want to read on

North America Europe Asia Pacific
South East Asia SAARC Middle East



This email has been sent to you in association with
www.biospectrumasia.com
Tell Us What You Think! Help us improve our newsletters.
Send us your feedback!
© Copyright 2026 MM ACTIV. All rights reserved.
To Unsubscribe click here.

Disclaimer : Please remember – by opting-in you are still able to opt-out at any time, by simply replying to this email at digital@mmactiv.com and typing 'unsubscribe' in the 'subject' field of any future emails. We promise only to send emails that we believe you will find interesting, relevant and current.
Your data will never be sold or shared with any third party, although we may communicate a message to you from a partner that we are in collaboration with.